Anavex Life Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	353	652	432	507	820	1,173
Market Cap Growth	-62.15%	50.88%	-14.85%	-38.17%	-30.06%	402.86%
Enterprise Value	267	565	307	361	664	1,037
Last Close Price	4.00	7.25	4.96	6.35	9.69	15.20
PB Ratio	4.37	8.06	4.01	3.78	5.65	9.01
P/TBV Ratio	4.37	8.06	4.01	3.78	5.65	9.01
Quick Ratio	11.56	11.56	8.80	12.27	14.92	14.93
Current Ratio	11.61	11.61	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-43.11%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%
Return on Assets (ROA)	-26.51%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%
Return on Capital Employed (ROCE)	-53.50%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%
Earnings Yield	-11.18%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%
Buyback Yield / Dilution	-2.18%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.